Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. | The company’s cobas ...

Request To Download Free Sample of This Strategic Report@ Introduction: The Vietnam PCR & NGS Based Diagnostic Testing Market Report offers a comprehensive analysis of the landscape and trends ...

Real-Time PCR (qPCR) market Insights: Used extensively in diagnostics, life sciences, and environmental testing ...

Leveraging gold-standard PCR technology, the cobas liat system claims to deliver outcomes in under 20 minutes.

More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...

Pike does not naturally belong in Gillsvannet, and the authorities wanted to eliminate them. Traditionally, researchers have ...

Objectives SLE is a multifaceted autoimmune disorder with a complex pathogenesis involving genetic, environmental and ...

This is a useful study that seeks to address the role of the TET family of DNA demethylation enzymes in pancreatic beta cell senescence in the context of type 2 diabetes (T2DM). Although the concepts ...

Tritrichomonas foetus (Tritric) is a microscopic menace that can turn a household into a battleground of chronic illness.

VANCOUVER, BC, CANADA, January 20, 2025 /EINPresswire / -- The MRD Testing market is expected to grow from an estimated USD 1351.5 million in 2024 to USD 3901.1 million in 2033, at a CAGR of 12.50%.

US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...